Stuart McAlpine, a partner at Cinven since 2003, has been appointed managing partner by the GP amid a management reshuffle that sees Hugh Langmuir step down from the role after a six-year tenure.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020